Latest News about SAGE
Recent news which mentions SAGE
   56 Biggest Movers From Yesterday
   
  
  
  February 17, 2022
  From Benzinga
 
   40 Stocks Moving In Wednesday's Mid-Day Session
   
  
  
  February 16, 2022
  From Benzinga
 
   Sage Therapeutics - Biogen Partnered Depression Drug Meets Main Goal In Late-stage Study
   
  
  
  February 16, 2022
  From Benzinga
 From InvestorPlace
 
   12 biotech stocks to consider buying now as prospects for the sector brighten this year
   
  
  
  February 06, 2022
  From MarketWatch
 
   New Psychedelics ETF Launches On NYSE Arca
   
  
  
  February 02, 2022
  From Benzinga
 
   Where Will Biogen Be in 5 Years?
   
  
  
  January 15, 2022
  From Motley Fool
 
   Mobile Clinics for Mental Health Treatments Reportedly Launching in Major Cities Across the U.S.
   
  
  
  December 28, 2021
  From Benzinga
 
   5 Value Stocks In The Healthcare Sector
   
  
  
  December 27, 2021
  From Benzinga
 
   The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom
   
  
  
  December 08, 2021
  From Benzinga
 
   5 Value Stocks To Watch In The Healthcare Sector
   
  
  
  December 06, 2021
  From Benzinga
 
   Sage Therapeutics - Biogen Share One Year Zuranolone 50mg Data In Depression Patients
   
  
  
  December 01, 2021
  From Benzinga
 From Benzinga
 
   These 60 stocks, including DraftKings, Zillow and Virgin Galactic, are down at least 50% from their 2021 highs
   
  
  
  November 29, 2021
  From MarketWatch
 
   Is Compass Pathways Stock a Once-in-a-Lifetime Bargain?
   
  
  
  November 11, 2021
  From Motley Fool
 
   12 Health Care Stocks Moving In Friday's After-Market Session
   
  
  
  November 08, 2021
  From Benzinga
 
   What 8 Analyst Ratings Have To Say About Sage Therapeutics
   
  November 03, 2021
  Tickers 
   SAGE
  
  
  From Benzinga
 
   10 Biggest Price Target Changes For Wednesday
   
  
  
  November 03, 2021
  From Benzinga
 
   Sage Therapeutics Inc (SAGE) Q3 2021 Earnings Call Transcript
   
  November 02, 2021
  Tickers 
   SAGE
  
  
  From Motley Fool
 
   How Bad Are Sage Therapeutics's Earnings? | Return On Capital Employed
   
  November 02, 2021
  Tickers 
   SAGE
  
  
  From Benzinga
 
   The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
   
  
  
  November 02, 2021
  From Benzinga
 
   Earnings Scheduled For November 2, 2021
   
  
  
  November 02, 2021
  From Benzinga
 
   The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
   
  
  
  October 31, 2021
  From Benzinga
 
   Should Biogen Investors Be Preparing for the Worst?
   
  
  
  October 27, 2021
  From Motley Fool
 
   3 Big Problems With Biogen's Q3 Results
   
  
  
  October 23, 2021
  From Motley Fool
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

